Does Continuous Insulin Therapy Reduce Postoperative Supraventricular Tachycardia Incidence After Coronary Artery Bypass Operations in Diabetic Patients?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 3, 2008, Pages 383-387

  Kirdemir, Pakize ^a   Yildirim, Vedat ^b   Kiris, Ilker ^a   Gulmen, Senol ^a   Kuralay, Erkan ^a   Ibrisim, Erdogan ^a   Ozal, Ertugrul ^b  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

coronary artery bypass surgery; insulin therapy; supraventricular tachycardia

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART EJECTION FRACTION; HEART OUTPUT; HEART VENTRICLE FIBRILLATION; HUMAN; INCIDENCE; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SUPRAVENTRICULAR TACHYCARDIA;

AGED; CORONARY ARTERY BYPASS; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 44149120786     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.09.015     Document Type: Article

References (24)

1. Cosgrove D.M., Loop F.D., Lytle B.W., et al. Determinants of 10-year survival after primary myocardial revascularization. Ann Surg 202 (1985) 480-490
2. Lawrie G.M., Morris Jr. G.C., and Glaeser D.H. Influence of diabetes mellitus on the results of coronary bypass surgery: Follow-up of 212 diabetic patients ten to 15 years after surgery. JAMA 256 (1986) 2967-2971
3. Herlitz J., Wognsen G.B., Emanuelsson H., et al. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 19 (1996) 698-703
4. Thourani V.H., Weintraub W.S., Stein B., et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 67 (1996) 1045-1052
5. Carson J.L., Scholz P.M., Chen A.Y., et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40 (2002) 418-423
6. Zerr K.J., Furnary A.P., Grunkemeier G.L., et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63 (1997) 356-361
7. Furnary A.P., Zerr K.J., Grunkemeier G.L., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67 (1999) 352-360
8. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Surg 125 (2003) 1007-1021
9. Yilmaz A.T., Demirkilic U., Arslan M., et al. Long-term prevention of atrial fibrillation after coronary artery bypass surgery: Comparison of quinidine, verapamil and amiodarone in maintaining sinus rhythm. J Card Surg 11 (1996) 61-64
10. Tyras D.H., Stothert J.C., Kaiser G.L., et al. Supraventricular tachyarrhythmias after coronary artery revascularization. A randomized trial of prophylactic digitalization. J Thorac Cardiovasc Surg 77 (1979) 310-314
11. Kuralay E., Cingöz F., Kilic S., et al. Supraventricular tachyarrythmia prophylaxis after coronary artery surgery in chronic obstructive pulmonary disease patients (early amiodarone prophylaxis trial). Eur J Cardiothorac Surg 25 (2004) 224-230
12. Borzak S., Tisdale J.E., Amin N.B., et al. Atrial fibrillation after bypass surgery. Does the arrhythmia or characteristics of the patients prolong hospital stay?. Chest 113 (1998) 1489-1491
13. Almassi G.H., Schowalter T., Nicolosi A.C., et al. Atrial fibrillation after cardiac surgery. A major morbid event. Ann Surg 226 (1997) 501-513
14. Tull D., and Albawn G.S. Appendix I. Survey Research: A Decisional Approach (1973), Intext Press Inc, New York 225
15. Gordis L. Epidemiology, in Randomized Trails: Some Further Issues. ed 2 (1996), WB Saunders, London 110-115
16. Abel R.M., VanGelder H.M., Pores I.H., et al. Continued propranolol administration following coronary bypass surgery. Arch Surg 118 (1983) 727-731
17. Iwey M.F., lwey T.D., Bailey W.W., et al. Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. A randomized trial. J Thorac Cardiovasc Surg 85 (1983) 214-218
18. Roffman J.A., and Fielman A. Digoxin and propranolol in the prophylaxis of supraventricular tachydysrhythmias after coronary artery bypass. Ann Thorac Surg 31 (1981) 496-500
19. Taegtmeyer H. Carbohydrate interconversions and energy production. Circulation 72 (1985) IV1-IV8
20. Saddik M., and Lopaschuk G.D. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 266 (1991) 8162-8170
21. Rao V., Merante F., Weisel R.D., et al. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia. J Thorac Cardiovasc Surg 116 (1998) 485-494
22. Lazar H.L., Zhang X., Rivers S., et al. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions. Ann Thorac Surg 60 (1995) 411-416
23. Lazar H.L. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions. J Card Surg 9 suppl (1994) 474-478
24. Lazar H.L., Chipkin S.R., Fitzgerald C.A., et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109 (2004) 1497-1502